Wastewater monitoring for COVID-19 and other pathogens is an efficient and highly scalable way to monitor populations for the prevalence of infections. It provides a rapid and direct measure of the level of infection throughout a population at risk, without the logistical barriers of conventional testing.
Most current protocols use laborious viral-precipitation methods that make it difficult to process more than a handful of samples per day. GT Molecular has developed a novel and fully operational workflow that dramatically increases the throughput.
GT Molecular participated in a multi-month collaboration with 20 WWTPs and Colorado State University and the result is an extremely sensitive, validated assay using the latest digital PCR technology and protocol to provide increased throughput at a significant cost savings.
“This kind of testing is very promising as an early warning system. If high levels of virus are showing up in wastewater, the hospitals can prepare for that change in their ICU capacity,” said Dr. Rose Nash, Director of R&D at GT Molecular.
A webinar reviewing best practices is available at https://in-situ.com/us/COVID19-wastewater-monitoring-webinar and discusses the following important topics:
About GT Molecular
GT Molecular was created to develop new molecular detection technology for cancer research and harmful pathogen detection. It was co-founded by Dr. Hanlee Ji, Senior Director of the Stanford Genome Technology Center and Associate Professor at the Stanford School of Medicine and Christopher McKee, Chairman of In-Situ Inc., an international water instrumentation company.
For more information on GT Molecular, please visit www.gtmolecular.com or contact [email protected].
Download a flyer about an upcoming GT Molecular webinar >
Sponsored post by GT Molecular
My Profile
